Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
boston blog main
boston top stories
clinical trials
inclisiran
life sciences
national blog main
national top stories
3
×
new york
new york blog main
new york top stories
regeneron pharmaceuticals
3
×
alnylam pharmaceuticals
cholesterol
pcsk9
pcsk9 inhibitors
praluent
repatha
sanofi
the medicines co.
alirocumab
biotech
data
deals
evolocumab
fda
ldl
mark timney
mt sinai hospital
novartis
peter wijngaard
prashant vaishnava
rna interference
san francisco blog main
san francisco top stories
the medicines company
What
cholesterol
drug
medco
3
×
medicines
fda
lowering
twice
aces
acquire
agreed
announced
big
billion
bringing
brings
cash
ceo
clears
closer
company
compound
deal
filing
flexible
inched
inclisiran
key
market
meant
medicine
morning
nasdaq
new
novartis
open
passed
phase
poised
positive
preps
Language
unset
Current search:
medco
×
amgen
×
" national top stories "
×
" regeneron pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing